This compound is a protected phosphoramidite reagent used as a pharmaceutical intermediate in the manufacturing of oligonucleotides. It features a purine base with dimethoxytrityl (DMT) and benzoyl protecting groups, along with a chloro(dimethylamino)phosphoryl moiety for coupling reactions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1044241-74-8
((2S,6R)-6-(2-Isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate
pharmaceutical intermediate
N4-Ac-C-(S)-GNA phosphoramidite
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
pharmaceutical intermediate
5'-DMT-PseudoUridine
pharmaceutical intermediate
Benzyl (3R)-3-aminopiperidine-1-carboxylate
pharmaceutical intermediate
2-Aminoethylmethylsulfone hydrochloride
pharmaceutical intermediate
Imidodicarbonic acid, 2-(3-nitro-2-pyridinyl)-, 1,3-bis(1,1-dimethylethyl) ester
pharmaceutical intermediate
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide
NURVOJDGJURYKG-BFXPVMCSSA-N
CN(C)P(=O)(OC[C@@H]1CN(C[C@@H](O1)N2C=NC3=C2N=C(NC3=O)NC(=O)CC4=CC=CC=C4)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)Cl